Supplementary Table 1-4, Supplementary Figure 1-2 from Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics

Supplementary Table 1: Clinical characteristics of patients whose tumors were utilized for phosphotyrosine peptide survey. Supplementary Table 2: Phosphorylated Proteins in RCC Cell Line and Tumor Samples. Supplementary Table 3: Phosphopeptides identified using the Andromeda search engine of 10 renal cell carcinoma cell lines. Supplementary Table 4: Supplementary Table 4. Label-free quantification of phosphopeptides identified using the Andromeda search engine of 15 clear cell and 15 papillary renal cell carcinoma tumors. Supplementary Figure 1: Tyrosine kinase inhibitors (0.5 μM) provide functional correlation. Supplementary Figure 2: Tyrosine kinase inhibitors (2.5 μM) provide functional correlation. Please note that this data, due to its large size, is represented best in Microsoft Excel.